COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma

Schadendorf, Dirk; Dummer, Reinhard; Flaherty, Keith T.; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B.; Garbe, Claus; Gogas, Helen J.; Gutzmer, Ralf; Krajsova, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandala, Mario; Yamazaki, Naoya; Queirolo, Paola; Guenzel, Carolin; Polli, Anna; Thakur, Mahgull; di Pietro, Alessandra; Ascierto, Paolo A.

COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma

Autor(en):

Schadendorf, Dirk; Dummer, Reinhard; Flaherty, Keith T.; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B.; Garbe, Claus; Gogas, Helen J.; Gutzmer, Ralf; Krajsova, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandala, Mario; Yamazaki, Naoya; Queirolo, Paola; Guenzel, Carolin; Polli, Anna; Thakur, Mahgull; di Pietro, Alessandra; Ascierto, Paolo A.

Tübinger Autor(en):

Garbe, Claus

Erschienen in:

European Journal of Cancer (2024), Bd. 204, Article 114073

Verlagsangabe:

London : Elsevier Sci Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.ejca.2024.114073

ISSN:

0959-8049